vs

Side-by-side financial comparison of Loar Holdings Inc. (LOAR) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

Loar Holdings Inc. is the larger business by last-quarter revenue ($131.8M vs $83.1M, roughly 1.6× PROCEPT BioRobotics Corp). Loar Holdings Inc. runs the higher net margin — 9.5% vs -38.1%, a 47.6% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 19.3%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 19.8%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

LOAR vs PRCT — Head-to-Head

Bigger by revenue
LOAR
LOAR
1.6× larger
LOAR
$131.8M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+0.9% gap
PRCT
20.2%
19.3%
LOAR
Higher net margin
LOAR
LOAR
47.6% more per $
LOAR
9.5%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
19.8%
LOAR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
LOAR
LOAR
PRCT
PRCT
Revenue
$131.8M
$83.1M
Net Profit
$12.5M
$-31.6M
Gross Margin
52.1%
64.9%
Operating Margin
18.0%
-4.1%
Net Margin
9.5%
-38.1%
Revenue YoY
19.3%
20.2%
Net Profit YoY
239.5%
-27.9%
EPS (diluted)
$0.13
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LOAR
LOAR
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$131.8M
$76.4M
Q3 25
$126.8M
$83.3M
Q2 25
$123.1M
$79.2M
Q1 25
$114.7M
$69.2M
Q4 24
$110.4M
$68.2M
Q3 24
$103.5M
$58.4M
Q2 24
$97.0M
$53.4M
Net Profit
LOAR
LOAR
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$12.5M
$-29.8M
Q3 25
$27.6M
$-21.4M
Q2 25
$16.7M
$-19.6M
Q1 25
$15.3M
$-24.7M
Q4 24
$3.7M
$-18.9M
Q3 24
$8.7M
$-21.0M
Q2 24
$7.6M
$-25.6M
Gross Margin
LOAR
LOAR
PRCT
PRCT
Q1 26
64.9%
Q4 25
52.1%
60.6%
Q3 25
52.7%
64.8%
Q2 25
53.8%
65.4%
Q1 25
52.1%
63.9%
Q4 24
48.9%
64.0%
Q3 24
51.1%
63.2%
Q2 24
49.0%
59.0%
Operating Margin
LOAR
LOAR
PRCT
PRCT
Q1 26
-4.1%
Q4 25
18.0%
-40.6%
Q3 25
22.9%
-27.8%
Q2 25
22.2%
-28.0%
Q1 25
22.8%
-39.7%
Q4 24
19.2%
-28.9%
Q3 24
22.1%
-38.4%
Q2 24
22.9%
-50.3%
Net Margin
LOAR
LOAR
PRCT
PRCT
Q1 26
-38.1%
Q4 25
9.5%
-39.1%
Q3 25
21.8%
-25.7%
Q2 25
13.6%
-24.7%
Q1 25
13.4%
-35.8%
Q4 24
3.3%
-27.6%
Q3 24
8.4%
-35.9%
Q2 24
7.9%
-48.0%
EPS (diluted)
LOAR
LOAR
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.13
$-0.54
Q3 25
$0.29
$-0.38
Q2 25
$0.17
$-0.35
Q1 25
$0.16
$-0.45
Q4 24
$-11023.48
$-0.34
Q3 24
$0.09
$-0.40
Q2 24
$0.09
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LOAR
LOAR
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$84.8M
$245.6M
Total DebtLower is stronger
$715.7M
$51.7M
Stockholders' EquityBook value
$1.2B
$347.7M
Total Assets
$2.0B
$487.1M
Debt / EquityLower = less leverage
0.61×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LOAR
LOAR
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$84.8M
$286.5M
Q3 25
$99.0M
$294.3M
Q2 25
$103.3M
$302.7M
Q1 25
$80.5M
$316.2M
Q4 24
$54.1M
$333.7M
Q3 24
$55.2M
$196.8M
Q2 24
$73.2M
$214.1M
Total Debt
LOAR
LOAR
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$715.7M
$51.6M
Q3 25
$279.4M
$51.6M
Q2 25
$277.7M
$51.5M
Q1 25
$277.5M
$51.5M
Q4 24
$277.3M
$51.5M
Q3 24
$602.1M
$51.4M
Q2 24
$250.7M
$51.4M
Stockholders' Equity
LOAR
LOAR
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$1.2B
$365.9M
Q3 25
$1.2B
$380.3M
Q2 25
$1.1B
$385.8M
Q1 25
$1.1B
$389.2M
Q4 24
$1.1B
$402.2M
Q3 24
$769.8M
$241.2M
Q2 24
$758.4M
$251.8M
Total Assets
LOAR
LOAR
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$2.0B
$508.1M
Q3 25
$1.5B
$511.5M
Q2 25
$1.5B
$513.1M
Q1 25
$1.5B
$519.4M
Q4 24
$1.5B
$534.0M
Q3 24
$1.5B
$374.1M
Q2 24
$1.1B
$374.4M
Debt / Equity
LOAR
LOAR
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.61×
0.14×
Q3 25
0.24×
0.14×
Q2 25
0.25×
0.13×
Q1 25
0.25×
0.13×
Q4 24
0.25×
0.13×
Q3 24
0.78×
0.21×
Q2 24
0.33×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LOAR
LOAR
PRCT
PRCT
Operating Cash FlowLast quarter
$30.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
2.43×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LOAR
LOAR
PRCT
PRCT
Q1 26
Q4 25
$30.4M
$-10.3M
Q3 25
$29.7M
$-6.6M
Q2 25
$23.8M
$-15.0M
Q1 25
$28.4M
$-17.0M
Q4 24
$20.7M
$-32.4M
Q3 24
$16.3M
$-18.8M
Q2 24
$7.1M
$-15.7M
Free Cash Flow
LOAR
LOAR
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
LOAR
LOAR
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
LOAR
LOAR
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%
Cash Conversion
LOAR
LOAR
PRCT
PRCT
Q1 26
Q4 25
2.43×
Q3 25
1.08×
Q2 25
1.42×
Q1 25
1.85×
Q4 24
5.62×
Q3 24
1.89×
Q2 24
0.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LOAR
LOAR

Other$76.8M58%
Commercial Aerospace$21.2M16%
Business Jet And General Aviation$17.6M13%
Defense$16.2M12%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons